Skip to main content
Swedish Orphan Biovitrum logo

Swedish Orphan Biovitrum — Investor Relations & Filings

Ticker · SOBI ISIN · SE0000872095 LEI · 549300124Y3MQI87PT35 ST Manufacturing
Open in API
Filings indexed 892 across all filing types
Latest filing 2017-04-12 Annual Report
Country SE Sweden
Listing ST SOBI

About Swedish Orphan Biovitrum

https://www.sobi.com/en

Swedish Orphan Biovitrum (Sobi) is a specialized biopharmaceutical company dedicated to developing and delivering innovative treatments for rare and debilitating diseases. The company's primary focus is on the therapeutic areas of haematology and immunology, with a significant legacy and continued leadership in haemophilia care. Sobi addresses the high unmet medical needs of patients by advancing a pipeline of innovative medicines and working to expand patient access globally. The company's mission is to transform the lives of people affected by rare conditions through dedicated research, development, and global collaboration.

Recent filings

Filing Released Lang Actions
Annual Report 2016
Annual Report Classification · 100% confidence The document is titled 'ÅRSREDOVISNING 2016' (Annual Report 2016) for the company Sobi. It contains comprehensive financial data, management commentary, board reports, and audit information for the full fiscal year 2016. It is clearly the primary annual report document, not an announcement or summary. FY 2016
2017-04-12 Swedish
Annual Report 2016
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2016' and contains comprehensive sections including a CEO's letter, business highlights, financial statements, a five-year summary, and a directors' report. It covers the full fiscal year of 2016 and provides detailed financial performance data, which aligns perfectly with the definition of an Annual Report (10-K). FY 2016
2017-04-12 English
Theresa Heggie avgår från styrelsen och kommer inte att föreslås till omval vid Sobis årsstämma 2017
Board/Management Information Classification · 98% confidence The document is a press release dated April 7, 2017, announcing that Theresa Heggie is resigning from the board of directors ('Theresa Heggie avgår från styrelsen') and will not be proposed for re-election at the upcoming Annual General Meeting (AGM). This directly concerns changes in the company's board of directors and senior governance structure. This aligns perfectly with the definition for Board/Management Information (MANG). It is not an AGM result (DVA), a proxy statement (PSI), or an announcement of the AGM itself (AGM-R), but rather a specific management change announcement.
2017-04-07 Swedish
Theresa Heggie resigns from the Board of Directors and will not be proposed for re-election at Sobi’s annual general meeting 2017
Board/Management Information Classification · 98% confidence The document explicitly announces the resignation of a Board of Directors member, Theresa Heggie, and mentions that she will not be proposed for re-election at the upcoming Annual General Meeting (AGM). This content directly relates to changes in the company's board of directors and senior management structure. This aligns perfectly with the definition for Board/Management Information (MANG). Although the AGM is mentioned, the core subject is the resignation, not the meeting materials or voting results.
2017-04-07 English
Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
AGM Information Classification · 99% confidence The document is explicitly titled 'Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)' and details the date, location, procedures for participation, and the proposed agenda for the meeting. The agenda items (e.g., Election of chairman, Determination of fees, Resolution regarding appropriation of profit, Resolution regarding guidelines for remuneration) are standard components of an Annual General Meeting (AGM) notice. This directly corresponds to the definition of AGM Information.
2017-03-30 English
Kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)
AGM Information Classification · 100% confidence The document is titled "Kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)" which translates to 'Notice of Annual General Meeting' in Swedish. It details the date, time, location, registration procedures, voting rights, and a detailed agenda for the meeting. The agenda includes items typical for an AGM, such as electing the chairman, approving the annual report (Item 7), deciding on profit distribution (Item 11), approving remuneration guidelines (Item 16), and electing board members and auditors (Item 15). This content directly corresponds to the purpose of an Annual General Meeting notice. Therefore, the classification is AGM-R.
2017-03-30 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.